Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study
Open Access
- 25 November 2020
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 20 (1) , 1-9
Abstract
Background: We anticipate large efficacy trials of novel HIV vaccines that have shown acceptable safety profiles. We determined willingness to participate (WTP) in future HIV vaccine efficacy trials among HIV negative female sex workers (FSWs) in Kampala Uganda. Methods: We conducted a case control study in the Good Health for Women Project cohort. Cases received HIV prevention services and, enrolled in a 12-month simulated vaccine efficacy trial (SiVET) that used Hepatitis B vaccine; they underwent vaccine trial procedures as would be in an actual trial. Controls received similar health services but did not enroll in SiVET. We matched cases and controls (ratio 2:1) for age and duration in the cohort. We described a hypothetical HIV vaccine trial to cases (after 9 months in SiVET) and controls including trial attributes: randomization, delaying pregnancy, frequent blood draws (80-100mls) and study visits for 3 years. We compared WTP and willingness for vaccine trial attributes by case/control using chi-squared or Fisher’s exact tests and fitted conditional logistic regression models to determine independent predictors of WTP. Results: We analyzed data for 311 volunteers (219 cases, 92 controls); median age 27 years (IQR: 23–32), 39.9% had ≥secondary education, 57.9% had sex work as their main job and 81.9% used illicit drugs. Compared to controls, more cases had lived in the community for > 1 year, (85.4% vs 64.1%; p < 0.001) and fewer cases reported illicit drug use in the past 3 months, (79.0% vs 89.1%; p = 0.03). Overall, 278 (89.4%) volunteers expressed WTP in an HIV vaccine trial, the most common reason being hope of protection against HIV. More cases than controls (58.2% vs 44.7%) did not need to consult anyone before trial participation (p = 0.03); cases were more willing to delay pregnancy (99.0% vs 94.0%; p = 0.03). Combining vaccine trial attributes, 249 (89.6%) of the 278 accepted all attributes. After controlling for case/ control status women with secondary education or higher expressed less WTP (aOR 0.17; 95% CI 0.04–0.80). Conclusion: FSWs in Kampala demonstrated high WTP. Prior experience with trial requirements like contraception may improve their uptake during actual trials. Family involvement is important for those without prior trial experience.Keywords
Funding Information
- IAVI
This publication has 28 references indexed in Scilit:
- Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in UgandaVaccine, 2013
- ‘It is like a tomato stall where someone can pick what he likes’: structure and practices of female sex work in Kampala, UgandaBMC Public Health, 2013
- Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trialsHuman Vaccines & Immunotherapeutics, 2013
- Human rights abuses and collective resilience among sex workers in four African countries: a qualitative studyGlobalization and Health, 2013
- Alcohol Use, Mycoplasma genitalium, and Other STIs Associated With HIV Incidence Among Women at High Risk in Kampala, UgandaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Recruitment of Urban US Women at Risk for HIV Infection and Willingness to Participate in Future HIV Vaccine TrialsAIDS and Behavior, 2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenNew England Journal of Medicine, 2012
- Socio-Demographic Characteristics and Behavioral Risk Factors of Female Sex Workers in Sub-Saharan Africa: A Systematic ReviewAIDS and Behavior, 2011
- Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studiesAIDS Care, 2011
- Factors Associated with Willingness to Participate in HIV Vaccine Trials among High-Risk Populations in South IndiaAIDS Research and Human Retroviruses, 2009